CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients

CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients

BackgroundTacrolimus is an approved first-line immunosuppressive agent for kidney transplantations. Part of interindividual and interethnic differences in the response of patients to tacrolimus is attributed to polymorphisms at CYP3A5 metabolic enzyme. CYP3A5 gene expression status is associated wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Effrosyni Mendrinou (Author), Mohamed Elsayed Mashaly (Author), Amir Mohamed Al Okily (Author), Mohamed Elsayed Mohamed (Author), Ayman Fathi Refaie (Author), Essam Mahmoud Elsawy (Author), Hazem Hamed Saleh (Author), Hussein Sheashaa (Author), George P. Patrinos (Author)
Format: Book
Published: Frontiers Media S.A., 2020-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items